What is the best management for a tracheostomy-related tracheoinnominate fistula?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Tracheostomy-Related Tracheoinnominate Fistula

Division of the innominate artery and ligation of both fistula ends is the best management for a tracheostomy-related tracheoinnominate fistula, as this approach has the lowest rebleeding rate and best long-term survival. 1

Initial Emergency Management

  • Tracheoinnominate fistula is a rare but potentially fatal complication of tracheostomy that requires immediate intervention 2
  • If bleeding is suspected from a tracheoinnominate fistula, immediate measures should include:
    • Hyperinflation of the tracheostomy tube cuff, if present 3
    • Alternatively, insertion of a cuffed tracheal tube via the stoma with the tip placed distal to the fistula 3
    • Digital pressure can be applied either directly or to the innominate artery site while preparing for definitive treatment 3
  • Standard resuscitation measures should occur simultaneously with emergency management 3

Diagnostic Considerations

  • A sentinel bleed is reported in approximately 50% of cases, making any bleeding from a tracheostomy site a concerning finding 3
  • Moderate bleeding from the stomal site or pulsation of the tracheostomy tube should raise suspicion for a tracheoinnominate fistula 3
  • Bronchoscopy and angiography may be performed but are often nondiagnostic 1

Definitive Surgical Management

  • Division of the innominate artery and ligation of both fistula ends is the preferred definitive treatment because:

    • It has a very low rebleeding rate (7%) 1
    • It provides good long-term survival (64%) 1
    • There is no convincing evidence that interruption of the innominate artery causes significant neurologic or vascular compromise 1
  • Attempting to maintain continuity of the innominate artery (such as with vein grafts or PTFE grafts) is contraindicated due to:

    • High rebleeding rate (60%) 1
    • Poor long-term survival (10%) 1

Alternative Approaches

  • Recent advances in endovascular technology have led to reports of successful treatment with:

    • Endovascular embolization of the innominate artery 4
    • Endovascular stent placement 5
  • However, these newer techniques:

    • May require multiple coils to inhibit blood flow into the fistula 4
    • Have less long-term outcome data compared to surgical ligation 4, 5
    • Should be considered only when surgical options are not feasible or are contraindicated 4

Surgical Technique Considerations

  • Successful management often involves:
    • Ligation and resection of the innominate artery at the fistula site 6
    • Placement of a pectoralis major muscle flap to separate the trachea from the vascular structures 6
    • Immediate control of bleeding with rapid transport to the operating room 6

Important Caveats

  • Mortality rates are high if definitive treatment is delayed 2
  • Peak incidence of tracheoinnominate fistula occurs 3 days to 6 weeks post-tracheostomy procedure 2
  • The reported incidence is 0.1%-1.0% after tracheostomy 2
  • Once bleeding occurs from a tracheoinnominate fistula, it is usually fatal without immediate intervention 2

References

Research

Tracheo-innominate artery fistula: two case reports and a clinical review.

Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tracheoinnominate fistula: surgical management of an iatrogenic disaster.

The Journal of laryngology and otology, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.